Nike Lawsuit Against Edison Chen Tops Shoe Industry News
ByAinvest
Tuesday, Aug 12, 2025 4:46 pm ET1min read
NKE--
The lawsuit claims that Clot used Nike's intellectual property without permission to create and sell shoes that resemble Nike's Air Force 1 and Air Jordan sneakers. The specifics of the allegations are not yet publicly available, but the case has drawn significant attention within the sneaker industry.
Edison Chen, an actor, singer, rapper, and fashion designer, co-founded Clot Inc. with partners Kevin Poon and Billy Ip. Clot has been a steady partner for Nike, having collaborated on over thirty different sneakers since their first project in 2006. However, their partnership ended abruptly in 2023 when Chen switched to Adidas [1].
Nike's lawsuit comes nearly two years after Chen's partnership with Adidas was disclosed. Clot and Adidas have since collaborated on several projects, including the Adidas Clot Gazelle and the Adidas Clot Stan Smith by Edison Chen [2].
The case is being closely monitored by industry experts and fans of the sneaker culture. The outcome of the lawsuit could have significant implications for the sneaker industry, particularly regarding intellectual property rights and collaborations between brands and designers.
References:
[1] https://www.soleretriever.com/news/articles/nike-sues-edison-chen-126-million-dollars-breach-of-contract-details
[2] https://wwd.com/footwear-news/shoe-industry-news/nike-126-6-million-lawsuit-clot-founder-edison-chen-1238034853/
Nike has filed a $126.6 million lawsuit against Clot founder Edison Chen, alleging trademark infringement and false endorsement. The lawsuit claims that Clot used Nike's intellectual property without permission to create and sell shoes that resemble Nike's Air Force 1 and Air Jordan sneakers. Nike is seeking damages and an injunction to stop Clot from further infringing on its trademarks.
Nike, a leading global athletic footwear and apparel company, has filed a lawsuit against Edison Chen, the founder of streetwear brand Clot, alleging trademark infringement and false endorsement. The lawsuit, filed in a federal district court in Los Angeles, seeks damages and an injunction to stop Clot from further infringing on Nike's trademarks [2].The lawsuit claims that Clot used Nike's intellectual property without permission to create and sell shoes that resemble Nike's Air Force 1 and Air Jordan sneakers. The specifics of the allegations are not yet publicly available, but the case has drawn significant attention within the sneaker industry.
Edison Chen, an actor, singer, rapper, and fashion designer, co-founded Clot Inc. with partners Kevin Poon and Billy Ip. Clot has been a steady partner for Nike, having collaborated on over thirty different sneakers since their first project in 2006. However, their partnership ended abruptly in 2023 when Chen switched to Adidas [1].
Nike's lawsuit comes nearly two years after Chen's partnership with Adidas was disclosed. Clot and Adidas have since collaborated on several projects, including the Adidas Clot Gazelle and the Adidas Clot Stan Smith by Edison Chen [2].
The case is being closely monitored by industry experts and fans of the sneaker culture. The outcome of the lawsuit could have significant implications for the sneaker industry, particularly regarding intellectual property rights and collaborations between brands and designers.
References:
[1] https://www.soleretriever.com/news/articles/nike-sues-edison-chen-126-million-dollars-breach-of-contract-details
[2] https://wwd.com/footwear-news/shoe-industry-news/nike-126-6-million-lawsuit-clot-founder-edison-chen-1238034853/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet